Rheumatoid Arthritis

 

Oral Glucocorticoids and Fracture Risk in RA

September 21, 2020

Low-dose oral glucocorticoid therapy increases only vertebral fracture risk in rheumatoid arthritis patients, a study shows.

Sarilumab Shown to Reduce Persistent Pain in RA

September 11, 2020

Report shows that sarilumab may be better at controlling severe and refractory pain in rheumatoid arthritis patients than adalimumab.

Prescribing Methotrexate with Anti-TNFs May Only Benefit Some RA Patients

September 04, 2020

Combining methotrexate with TNF inhibitors may only be worthwhile for rheumatoid arthritis patients who are seropositive, the results of a small study suggest.

The Art of Discontinuing Glucocorticoids in Rheumatoid Arthritis

September 04, 2020

Continuous low-dose glucocorticoid regimens are better than tapering for controlling disease activity in rheumatoid arthritis over a six-month period, show the results of the first double blind clinical trial to evaluate an oral glucocorticoid dose-tapering regimen with stable biological background therapy in rheumatoid arthritis.

DMARD Treatment for Early RA Improves Heart Disease

September 03, 2020

Vascular stiffness―which is often the precursor to a major cardiovascular event―appears to be present in early rheumatoid arthritis, shows a new study published in the Annals of the Rheumatic Diseases.

Treatment Combinations in RA May Not Be So Unique After All

August 11, 2020

In an interview with Rheumatology Network, Dr. Beate Wieseler compares the effectiveness of biologic drugs used to treat rheumatoid arthritis after methotrexate fails.

Methotrexate Not Associated with Lung Disease in RA

August 11, 2020

The prior use of methotrexate for rheumatoid arthritis patients doesn't seem to be associated with an increased risk of developing fibrotic interstitial lung disease, a common and potentially deadly complication of RA.

Diabetes More Common in PsA Than RA

August 06, 2020

Researchers writing in Arthritis Care and Research this week report that rheumatoid arthritis patients actually have a lower rate of type 2 diabetes than people without RA or patients with hypertension, osteoarthritis and psoriatic arthritis.

Podcast: Overdrive From Rheumatology Network with Dr. Jeffrey Sparks

August 02, 2020

In today's issue of Overdrive, a podcast from Rheumatology Network, we talk with Dr. Jeffrey Sparks, a rheumatologist with Brigham and Women’s Hospital in Boston who recently addressed the importance of an interdisciplinary and individualized approach in treating rheumatic disease patients who have Interstitial lung disease, a condition that can lead to worsen morbidity and mortality. Learn more in this interview.

Interdisciplinary Medicine Is Best in Rheumatology

July 31, 2020

In this week's news roundup from Rheumatology Network, we talk with Dr. Jeffrey Sparks, a rheumatologist with Brigham and Women’s Hospital in Boston who recently addressed the importance of an interdisciplinary and individualized approach in treating rheumatic disease patients who have interstitial lung disease, a condition that can lead to worsen morbidity and mortality. Learn more in this interview.